Multitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis.

Wang, Zexing

Multitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis. [electronic resource] - European journal of clinical pharmacology May 2014 - 531-8 p. digital

Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review

1432-1041

10.1007/s00228-014-1654-5 doi


Angiogenesis Inhibitors--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Breast Neoplasms--blood supply
Disease-Free Survival
Female
Humans
Molecular Targeted Therapy
Neoplasm Metastasis
Protein-Tyrosine Kinases--antagonists & inhibitors
Randomized Controlled Trials as Topic